 |
|
|
|
|
|
|
 |
 |
|
|
 |
|
|
|
About 44% of office-based physicians used electronic health records (EHRs) in 2009, representing...
|
|
 |
|
|
 |
|
|
|
An investigation from the Therapeutics and Technology Assessment Subcommittee of the American...
|
|
 |
 |
|
|
|
Patients with a diagnosis of pernicious anemia (PA) appear to have an elevated risk of hip...
|
|
 |
|
|
 |
|
|
|
A Joint Commission report has found that hospitals continue to improve the quality and safety of...
|
|
 |
|
|
 |
|
|
|
The FDA has approved tocilizumab (Actemra, Roche) for the treatment of adult patients with...
|
|
 |
|
 |
This Week's Feature Story
|
|
|
|
Conference Highlights: ISET 2010
The International Symposium on Endovascular Therapy, or ISET, held its 2010 annual meeting from January 17-21 in Hollywood, Florida. The features below highlight some of the news emerging from the meeting. For more information on these items and other research that was presented, go to www.iset.org.
[ More ]
|
|
 |
|
|
 |
|
|
|
A tailored treatment strategy appears to help prevent more coronary artery disease (CAD) events while treating fewer people with high-dose statins than LDL cholesterol-based target approaches, according to a national study. Researchers compared tailored treatments based on a person’s 5-year CAD risk with treat-to-target approaches that escalate statin doses per National Cholesterol Education Program (NCEP) III guidelines.
[ More ]
|
|
 |
 |
|
|
|
A significant range of psychiatric disorders appears to occur after traumatic injuries, according to findings from a prospective cohort study. At 1 year after injury, 31% of patients reported a psychiatric disorder, and 22% developed a psychiatric disorder that they had never experienced before.
[ More ]
|
|
 |
 |
|
|
|
Swedish research suggests that persistent secondary prevention treatment declines rapidly during the first 2 years after stroke, particularly for statins and warfarin. The proportion of patients who were persistent users of drugs prescribed at hospital discharge declined progressively over the first 2 years.
[ More ]
|
|
 |
|
 |
|
|
 |
 |
Extending Survival for HIV-Infected Patients |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
| ELENA LOSINA, PHD |
| Director of Methodology Program in HIV Epidemiology/Outcomes Research, Division of General Medicine; Massachusetts General Hospital. Associate Professor of Orthopedic Surgery, Brigham and Women's Hospital; Harvard Medical School |
|
 |
|
 |
 |
 |
|
 |